You are here: Industry Insights > Vaccine

News List

Chance for global vaccine makers? China’s latest vaccine scandal sparks fury and fear fiercepharma
July 24, 2018
The bad news: China’s latest vaccine scandal, with its second-largest rabies vaccine maker at front and center, went berserk on social media over the weekend.
CR UK tests Asterias’ novel lung cancer immunotherapy jab pharmatimes
July 10, 2018
Cancer Research UK has begun testing a novel immunotherapy vaccine for lung cancer in Phase I trials, under a collaboration agreement with Asterias Biotherapeutics.
Researcher uses HPV vaccine to treat patient with skin cancer europeanpharmaceuticalreview
July 05, 2018
Evidence suggests the human papillomavirus plays a role in the development of some types of this skin cancer…
New hope for a syphilis vaccine europeanpharmaceuticalreview
June 14, 2018
Researchers have identified exterior proteins on the bacteria that could serve as vaccine targets for syphilis.
GlaxoSmithKline to pass $10B in 2024 vaccine sales, with Merck, Sanofi and Pfizer rounding out the top 4: report fiercepharma
June 13, 2018
Shingrix may not make it on the top 5 best-selling vaccines list in 2024...
Korea's GC Pharma establishes vaccine development firm in Seattle biospectrumasia
May 28, 2018
The new company aims to bring together GC Pharma's commercial scale vaccine development expertise and deep understanding of protein science with IDRI and MIBR's world class scientific expertise in vaccine, adjuvant and formulation development
Cancer vaccine strategy blocks death of tumour-specific cytotoxic T cells europeanpharmaceuticalreview
May 03, 2018
New research could serve as the stepping-stone in constructing vaccines with a greater likelihood of finding and attacking…
Manufacturing hiccup in China trips up Sanofi's vaccine sales momentum fiercepharma
May 02, 2018
After a strong 2017, Sanofi Pasteur got off to a less-than-stellar start this year. In China, inspectors put a temporary kibosh on imports ...
Pfizer vaccine receives FDA's breakthrough therapy designation biospectrumasia
April 26, 2018
As of 2016, the burden of MenB is highest in adolescents/young adults (32%) and infants (20%), followed by children ages 1 to 4 years (12%) and children ages 5 to 10 years (4%)
New vaccine could help people overcome cathinone abuse europeanpharmaceuticalreview
April 24, 2018
Researchers have developed a vaccine for one of the most dangerous types of synthetic cathinones…

Previous page 1 2 3 4 5 6 7 8 9 10 ... 99 100 Next page